Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.84
Bid: 0.836
Ask: 0.842
Change: 0.00 (0.00%)
Spread: 0.006 (0.718%)
Open: 0.83
High: 0.842
Low: 0.83
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: Pendragon yearly profit falls as costs rise

Wed, 22nd Mar 2023 14:36

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

--------

Pendragon PLC - Nottingham, England-based automotive retailer - Says revenue for 2022 grows to GBP3.62 billion from GBP3.45 billion in 2021. Pretax profit, however, falls by 26% to GBP45.5 million from GBP61.5 million, while underlying pretax profit declines by 31% to GBP57.6 million from GBP83.0 million. Underlying net finance costs increase by 23% to GBP40.9 million from GBP33.3 million a year earlier. Declares no dividend for 2022, same as 2021. Looking ahead, says it is pleased with the first two months of 2023, with underlying operating profit to February ahead of 2022 as volumes in both new and used cars have shown good year-on-year growth. Adds that it is confident in the prospects for the group in the year ahead.

--------

GCM Resources PLC - Phulbari coal and power project in north-west Bangladesh - Pretax loss narrows to GBP693,000 for the six months ended on December 31 from GBP763,000 a year before. Says the most significant expenditure during the period is pre-development expenditure. Administrative expenses ibcrease to GBP368,000 from GBP352,000. Looking ahead, warns that Bangladesh's economy will be disadvantaged by ongoing supply constraints and high prices.

---------

BioPharma Credit PLC - Exeter-based life sciences debt investor - Reports total income of USD218.1 million for 2022, up from USD103.9 million in 2021. Net asset value per share amounts to USD1.0139 as at December 31, up from USD0.9926 on the same a date in 2021. Declares a dividend of 13.1 cents per share for 2022, up 87% from 7.0 cents a year prior. Looking ahead, expects its investment pipeline to grow as new products and companies enter the market in 2023 and beyond.

---------

Literacy Capital PLC - London-based investment trust focused on opportunities to invest for the long-term in growing private UK businesses - Says net asset value amounts to 420.6 pence per share at December 31, up from 320.0p as at March 31. Net assets amount to GBP252.4 million for the nine months period. Chief Executive Officer Ricahrd Pindar says: "We are pleased with the performance of Book's portfolio in this nine-month period, with the continued strong trading across its portfolio companies, contributing to a NAV uplift of 31.4%." Says portfolio enters 2023 demonstrating strong tailwinds and momentum.

--------

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Oct 2018 11:33

BioPharma Credit Increases Placing Size To USD200 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong investor demand.Last Friday,

Read more
24 Oct 2018 09:02

BioPharma Credit increases placing following 'strong investor demand'

(Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded its original target.

Read more
19 Oct 2018 11:26

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a

Read more
27 Sep 2018 12:43

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to

Read more
20 Sep 2018 13:31

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in

Read more
2 Jul 2018 12:55

BioPharma Funds USD200 Million TESARO Loan Alongside Other Investors

LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and

Read more
4 May 2018 12:26

Pablo Legorreta Doubles BioPharma Credit Stake To 7.1% (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief

Read more
2 May 2018 16:51

Pharmaceutical Investors Cuts BioPharma Credit Stake Below 3% (ALLISS)

LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a

Read more
1 May 2018 16:26

BioPharma Invests USD194 Million In US Pharma Firm Sebela

LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a

Read more
23 Apr 2018 13:06

BioPharma Credit To Invest USD191 Million In Pharmaceutical Developer

LONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed will

Read more
8 Mar 2018 12:21

BioPharma Credit To Raise USD300 Million As Net Asset Value Rises (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.